Cancer Immunotherapy: Bridging Basic Research and Clinical Translation (N2)
January 1-4, 2027
| Location to be Determined
Ana Carrizosa Anderson
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Saturday, January 2, 2027
| 8:00–9:00 AM |
Welcome and Keynote Address |
|
| |
Antoni Ribas †, University of California, Los Angeles
How Tumors Enable Immunotherapy |
|
| 9:00–11:15 AM |
Reimagining Checkpoint Targeted Therapies |
|
| |
Ivan Diaz-Padilla, GlaxoSmithKline
Lessons from Checkpoint Blockade Trials |
|
| |
Andrea Cercek †, Memorial Sloan Kettering Cancer Center
Neoadjuvant Checkpoint Blockade in MMRd Cancer |
|
| |
Drew M. Pardoll, Johns Hopkins University School of Medicine
Understanding Resistance to Checkpoint Inhibition based on Neoadjuvant Clinical Trials |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–12:15 PM |
Women in Science Mentoring |
|
| 11:15–1:00 PM |
Poster Setup |
|
| 11:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Circadian Control of Cancer Immunotherapy |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Biological Insights from Systems that Model Human Cancer |
|
| |
Daniela Thommen †, Netherlands Cancer Institute
Rewiring T Cells in PD1 Resistant Tumors |
|
| |
Neta Erez, Tel Aviv University
Stromal and Immune Plasticity Shape the Metastatic Niche |
|
| |
Raza Ali †, University of Cambridge
Systems Cancer Pathology |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Harnessing Innate Cells for Cancer Therapy |
|
| |
Katy Rezvani †, University of Texas MD Anderson Cancer Center
NK-CARS |
|
| |
Lydia Lynch †, Princeton University
Targeting Innate T Cells in Cancer (MAIT , gdT, and iNKT) |
|
| |
Judith A. Varner †, University of California, San Diego
Macrophage Directed Immunotherapies |
|
| |
Marco Colonna †, Washington University School of Medicine
Trem2 based Therapies in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Mechanisms Shaping T Cell Differentiation in Cancer |
|
| |
Mary Philip †, Vanderbilt University Medical Center
Early CD8+ T Cell Fate Commitment in Cancer |
|
| |
Ana Carrizosa Anderson, Harvard Medical School
Talk Title to be Announced |
|
| |
Jean-Christophe Beltra †, University of Basel
Cytokine-Directed Gene Programs Shaping CD8+ T Cell Differentiation in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Applying Engineering and Materials Science to Cancer Immunotherapy |
|
| |
David J. Mooney †, Harvard University
Engineering T Cell Cancer Therapies |
|
| |
Naimish Patel †, CRISPR Therapeutics
Therapeutic Applications of CRISPR |
|
| |
Peter Benedict Kirk †, Immunocore
Bi-Specific T Cell Engagers (BiTes) |
|
| |
Jamie Spangler †, Johns Hopkins University
Engineering Proteins for Immunotherapy |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Cancer Neuroscience |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Pushing the Envelope in Cancer Vaccines: Generation and Application |
|
| |
Yardena Samuels †, Weizmann Institute of Science
Novel Mechanisms Producing Targetable Tumor Antigens |
|
| |
Eduardo Vilar-Sanchez †, University of Texas MD Anderson Cancer Center
Cancer Vaccines for Immunoprevention |
|
| |
Özlem Türeci †, BioNTech
Next Generation Cancer Vaccines |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
